Navigation Links
Parkinson’s Drug Linked to Gamblin

A new study finds an unusual side effect from drug therapy in some Parkinson’s patients. Certain dopamine agonists show signs of causing some patients to become excessive gamblers.
Dopamine is a chemical substance that is produced in the brain that allows people to have smooth movements. Parkinson’s patients have a severe shortage of dopamine. Drug therapies for Parkinson’s focus on increasing dopamine. //Researchers at Muhammad Ali Parkinson Research Center in Phoenix conducted a study to see if excessive gambling could be a side effect of one drug therapy.

For the study, researchers looked at the data of 1,884 patients who were seen at the center during one year. They found nine patients had gambling problems. All nine were taking levodopa and a dopamine agonist. In the brain levodopa is transformed into dopamine. The other study drug activates the dopamine receptor in the brain.

None of the patients had a previous history of gambling. Researchers say seven of the patients started gambling within one month after their dosage of the dopamine agonist was increased. All of the patients were in the advanced stages of the disease. Study authors say the gambling was severe enough to cause financial problems and two of the patients lost more than $60,000.

Researchers say after a caretaker or family member noticed the gambling problem, the patients’ drug therapies were changed. For most of the patients the new treatment plan fixed the problem. Researchers feel higher dosages of dopamine agonist may be to blame for excessive gambling. They add while the risk of this side effect is small, doctors need to inform patients about this unusual side effct.
'"/>




Page: 1

Related medicine news :

1. NPIL withdraws Parkinson’s dru
2. Delaying Parkinson’s Diseas
3. New Drug For Parkinson’s Disease With Less Side Effect
4. Embryonic Cells Might Prevent Parkinson’s Disease From Worsenin
5. Magnetic Stimulation For Parkinson’s Diseas
6. Exercising regularly can reduce the risk of Parkinson’s diseas
7. Fetal Cell Transplant Found To Improve Movement In Patients With Parkinson’s Disease
8. New Medicine For Parkinson’s disease
9. A New Addition Could Help Patients With Parkinson’s Disease
10. Milk intake increases the risk of Parkinson’s disease in midlife
11. Ibuprofen to lower risk of Parkinson’s diseas
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... , ... September 20, 2017 , ... “The Foggy Road to Moorwick”: the adventures of ... is the creation of published author, Jeanine Liston, a busy mother of five who used ... “I have been writing this book for over twenty years. It was a way ...
(Date:9/19/2017)... Houston, Texas (PRWEB) , ... September 19, 2017 ... ... Win Promotions and the Brazilian jiu-jitsu community have raised more than $15,000 in ... to the mats in professional submission grappling matches and world-class instructor seminars, organizers ...
(Date:9/19/2017)... , ... September 19, 2017 , ... Trusted debt-reduction firm ... 175,000 debt accounts, translating to in excess of $835 million in resolved debt for ... other unsecured loans are some of the categories of debt settled by the company. ...
(Date:9/19/2017)... Hill, CT (PRWEB) , ... September 19, 2017 ... ... support, today announced the winners of the Entrepreneur Innovation Awards (EIA), held this ... all of whom are Connecticut-based companies and entrepreneurs, presented their innovative project ideas ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... Society of Professional Benefit Administrators (SPBA) hosted “Expanding Your Success” with an ... Members as it focused on best practices for third party administrators (TPAs) related ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... , Sept. 12, 2017  Consumer reviews on the independent ... as the number one company for hearing aids, ranking it ... fifteen other brands. ... Hearing Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that provides high performance, ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
(Date:9/7/2017)... -- NuvoAir (formerly called Pond Healthcare Innovation), the ... with Novartis Pharma AG to distribute NuvoAir,s spirometry technology to ... mobile spirometry platform and Novartis, commitment to address the unmet ... ... ...
Breaking Medicine Technology: